• EP 159: Engineering macrophages to tackle rare disease with Noam Baumatz of Noga Therapeutics

  • Oct 31 2024
  • Length: 44 mins
  • Podcast

EP 159: Engineering macrophages to tackle rare disease with Noam Baumatz of Noga Therapeutics

Listen for free

View show details

  • Summary

  • In this episode, we’re joined by Noam Baumatz, CEO and Co-Founder of Noga Therapeutics, a company dedicated to developing gene therapies for rare and severe diseases through engineering macrophages. Motivated by his highly personal experience of rare disease, Noam founded Noga to develop the type of gene therapies his daughter was unable to access. He and Patrick discuss his work with parents and families affected by rare disease, the road to effective, financially accessible gene therapies, and Noam’s previous work in traditional Chinese medicine.
    Show more Show less
Show more Show less
activate_Holiday_promo_in_buybox_DT_T2

What listeners say about EP 159: Engineering macrophages to tackle rare disease with Noam Baumatz of Noga Therapeutics

Average customer ratings

Reviews - Please select the tabs below to change the source of reviews.

Audible.com reviews

Amazon reviews
No Reviews are Available